Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Index levels matter because they summarize broader market dynamics. This snippet covers why they matter and how traders can incorporate them.
27,318 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Can Meta be a profitable addition to your portfolio? This guide weighs AI progress, cash flow, and valuation signals ...
Elon Musk’s xAI sent a rare media email about a Memphis turbine permit, signaling a public-facing shift and the retur...
Nvidia sits at the center of a fast-changing tech stack. This article breaks down how the company can reach higher st...
Intel overcame a tough 12 months to deliver a striking rebound. Analysts say the AI-led strategy and foundry expansio...
As travel demand rebounds, investors want clarity on which cruise stock to buy in 2026. This guide contrasts Royal Ca...
Gas prices can ripple through a retailer’s results. This article explores what Walmart says about consumer stress, ho...
A Life360 board director recently sold several thousand shares after exercising options, timing that coincides with a...
Lucid Group has ambitious plans, but shifting from carmaker to tech supplier brings new risks. This article explains ...
Ripple XRP pushed past a major resistance, signaling a relief rally amid a cautious crypto backdrop. Traders weigh th...
Xcel Brands faces a pivotal year in 2025 as it leans on licensed partnerships and cost discipline. This guide outline...
A deal of this size reshapes risk, rewards, and portfolio strategy. Here is the thing investors should know and pract...